Uterine Manipulation Devices Market To Reach $421.7 Million By 2030

Uterine Manipulation Devices Market Growth & Trends

The global uterine manipulation devices market size is expected to reach USD 421.7 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.9% from 2023 to 2030. A surge in the prevalence of gynecological diseases, coupled with the rising preference for minimally invasive surgical procedures, is a key driving factor for the market.

The increasing prevalence of various gynecological disorders and the growing adoption of uterine manipulation devices owing to their ease of use and convenience are among factors expected to boost the market growth during the forecast period. The prevalence of UF tumors increases as women grow older and it is prevalent in over 30% of women aged between 40 and 60. UF usually develops in women in their late 40s and early 50s, though in some women it may occur at a younger age. Thus, the increasing number of women suffering from UF has led to a rise in the number of hysterectomy procedures, leading to significant demand for uterine manipulation devices.

Moreover, several key players are investing in R&D for the launch of innovative minimally and noninvasive surgical instruments. Currently, various advanced manipulators are available in the market. For instance, during colpotomy procedure, usually manipulators with a cup to fit over the cervix are preferred. These include RUMI in combination with KOH cups (by CooperSurgical, Inc.) and VCare (by CONMED Corporation). Therefore, various advantages offered by these devices are cumulatively responsible for boosting the demand for minimally invasive procedures, thereby propelling the market growth.

 Request a free sample copy or view report summary: Uterine Manipulation Devices Market Report

Uterine Manipulation Devices Market Report Highlights

• In terms of application, the total laparoscopic hysterectomy (TLH) segment held the largest revenue share of 38.5% in 2022. The growing preference for minimally invasive procedures is the major factor propelling the segment growth

• In terms of end use, the hospitals segment held the largest revenue share of 59.3% in 2022. The segment growth is majorly attributed to the increase in the number of patients suffering from various gynecological conditions

• The Asia Pacific market is expected to witness the fastest growth over the forecast period owing to the growing foreign investment to enter the economically developing countries

Uterine Manipulation Devices Market Segmentation

Grand View Research has segmented the global uterine manipulation devices market based on application, end-use, and region:

Uterine Manipulation Devices Application Outlook (Revenue in USD Million, 2018 - 2030)

• Total Laparoscopy Hysterectomy (TLH)

• Laparoscopic Supracervical Hysterectomy (LSH)

• Laparoscopically Assisted Vaginal Hysterectomy (LAVH)

• Sacrocolpopexy

• Others

Uterine Manipulation Devices End-use Outlook (Revenue in USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Ambulatory Surgery Centers (ASCs)

Uterine Manipulation Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players of Uterine Manipulation Devices Market

• Conkin Surgical Instruments Ltd.

• Johnson and Johnson

• CooperSurgical, Inc.

• B. Braun Medical Ltd.

• KARL STORZ GmbH & Co. KG

• CONMED Corporation

• RUDOLF Medical GmbH + Co. KG

• LiNA Medical ApS

• Richard Wolf GmbH

• Utah Medical Products, Inc.

• Purple Surgical

• Clinical Innovations, LLC

• Bissinger Medizintechnik

• The O.R. Company (Symmetry Surgical Inc.)

• LSI Solutions, Inc.